JEFFS ROGER — SEC Form 4 filings
SEC reporting owner CIK 1231615. 35 Form 4 filings on record with FilingPulse; latest filed 2026-07-14.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2024-01-16 to 2026-07-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 47 legs across 27 filings — 958,553 shares, $49,814,223 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: sale of 66,610 shares @ $37.43 ($2,493,212) in Liquidia Corp, filed 2026-01-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Liquidia Corp (LQDA) | Chief Executive Officer, Director | 24 | — | 36 legs · 815,500 sh · $34,041,275 | 26 |
| Axsome Therapeutics, Inc. (AXSM) | Director | 11 | — | 11 legs · 143,053 sh · $15,772,948 | 14 |
Form 4 filings — JEFFS ROGER
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-14 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 13,834 · Option exercise (M): 14,333 · Sale (S): 2,505 @ $71.39 · Sale (S): 32,744 @ $71.52 · Option exercise (M): 13,834 (derivative) @ $0 · Option exercise (M): 14,333 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 286 @ $246.18 · Sale (S): 286 @ $249.12 | EDGAR |
| 2026-06-10 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 1,429 · Option exercise (M): 1,429 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 1,721 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Liquidia Corp (LQDA) | Sale (S): 6,428 @ $62.18 | EDGAR |
| 2026-05-26 | 4 | Liquidia Corp (LQDA) | Sale (S): 25,000 @ $61.13 · Sale (S): 25,000 @ $61.52 · Sale (S): 25,000 @ $60.38 | EDGAR |
| 2026-05-20 | 4 | Liquidia Corp (LQDA) | Sale (S): 25,000 @ $56.77 · Sale (S): 25,000 @ $58.65 · Sale (S): 25,000 @ $61.30 | EDGAR |
| 2026-05-15 | 4 | Liquidia Corp (LQDA) | Sale (S): 25,000 @ $56.29 · Sale (S): 25,000 @ $58.62 · Sale (S): 25,000 @ $57.04 | EDGAR |
| 2026-05-12 | 4 | Liquidia Corp (LQDA) | Sale (S): 25,000 @ $42.14 · Sale (S): 25,000 @ $41.50 · Sale (S): 25,000 @ $54.04 | EDGAR |
| 2026-05-07 | 4 | Liquidia Corp (LQDA) | Sale (S): 25,000 @ $40.10 · Sale (S): 25,000 @ $40.78 · Sale (S): 25,000 @ $42.09 | EDGAR |
| 2026-04-21 | 4 | Liquidia Corp (LQDA) | Sale (S): 18,839 @ $40.60 | EDGAR |
| 2026-04-16 | 4 | Liquidia Corp (LQDA) | Sale (S): 3,300 @ $40 · Sale (S): 25,000 @ $40.14 · Sale (S): 25,000 @ $40.31 | EDGAR |
| 2026-04-14 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 13,834 · Option exercise (M): 14,333 · Sale (S): 32,744 @ $38.37 · Sale (S): 21,433 @ $40.12 · Option exercise (M): 13,834 (derivative) @ $0 · Option exercise (M): 14,333 (derivative) @ $0 | EDGAR |
| 2026-04-13 | 4 | Liquidia Corp (LQDA) | Sale (S): 25,000 @ $40.12 | EDGAR |
| 2026-01-21 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 115,344 @ $0 · Grant/award (A): 173,016 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 13,833 · Option exercise (M): 57,332 · Sale (S): 66,610 @ $37.43 · Option exercise (M): 13,833 (derivative) @ $0 · Option exercise (M): 57,332 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 13,834 · Sale (S): 20,261 @ $23.41 · Option exercise (M): 13,834 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 13,464 @ $123.68 | EDGAR |
| 2025-08-29 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 20,000 @ $122.30 · Sale (S): 20,000 @ $121.60 · Sale (S): 20,000 @ $121.27 | EDGAR |
| 2025-08-26 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 16,694 @ $120.08 · Sale (S): 20,000 @ $120.03 | EDGAR |
| 2025-07-15 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 13,833 · Sale (S): 20,252 @ $14.28 · Option exercise (M): 13,833 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 13,833 · Sale (S): 20,252 @ $14.28 · Option exercise (M): 13,833 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 3,166 (derivative) @ $0 · Grant/award (A): 1,429 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 69,169 · Sale (S): 30,610 @ $16.97 · Option exercise (M): 69,169 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Liquidia Corp (LQDA) | Sale (S): 14,130 @ $13.57 | EDGAR |
| 2025-02-25 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 1,408 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 229,327 @ $0 · Sale (S): 22,343 @ $11.78 · Grant/award (A): 229,327 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | Liquidia Corp (LQDA) | Sale (S): 8,053 @ $11.11 | EDGAR |
| 2024-07-15 | 4 | Liquidia Corp (LQDA) | Sale (S): 8,053 @ $12.53 | EDGAR |
| 2024-06-11 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 5,799 (derivative) @ $0 | EDGAR |
| 2024-04-16 | 4 | Liquidia Corp (LQDA) | Sale (S): 8,360 @ $14.58 | EDGAR |
| 2024-03-19 | 4 | Liquidia Corp (LQDA) | Sale (S): 28,583 @ $15.82 | EDGAR |
| 2024-03-15 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 13,000 @ $22.03 · Sale (S): 13,000 @ $69.70 · Option exercise (M): 16,976 @ $25.53 · Sale (S): 16,976 @ $69.70 · Option exercise (M): 2,347 @ $29.91 · Sale (S): 2,347 @ $71.61 · +3 more | EDGAR |
| 2024-02-29 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 1,425 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 221,338 @ $0 · Grant/award (A): 221,338 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1231615 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →